SCHEMBL13461573

SCHEMBL13461573

CC(=NOS(=O)(=O)c1ccc(C)cc1)c1ccc(-c2ccc(-c3ccccc3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PTGES O14684 1/20 0.42
ALOX5 P09917 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 3/20 0.41
PPARG P37231 1/20 0.40
PPARA Q07869 1/20 0.40
S1PR1 P21453 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
LMNA P02545 2/20 0.39
MAPK1 P28482 1/20 0.39
KEAP1 Q14145 1/20 0.39
NFE2L2 Q16236 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL92088 0.91 LMNA (0.46) SMN1; SMN2CASP3SENP8SENP7SENP6
SCHEMBL31565026 0.91 LMNA (0.46) SMN1; SMN2CASP3SENP8SENP7SENP6
Nitrous Acid SCHEMBL6396175 0.87 LMNA (0.43) CASP3SENP8SENP7SENP6L3MBTL1
Nitrous Acid SCHEMBL6396171 0.87 LMNA (0.43) CASP3SENP8SENP7SENP6L3MBTL1
SCHEMBL13033693 0.86 STAT3 (0.51) SMN1; SMN2CASP3SENP8SENP7SENP6
SCHEMBL14395720 0.83 CYP1A2 (0.58) SMN1; SMN2L3MBTL1MEN1KMT2AMAPT
SCHEMBL13969947 0.82 MAPT (0.53) L3MBTL1KMT2AMAPTPPARGPPARA
SCHEMBL212829 0.82 MAPT (0.53) L3MBTL1KMT2AMAPTPPARGPPARA
SCHEMBL13567344 0.82 ALDH1A1 (0.53) MEN1KMT2AMAPTALDH1A1CYP1A2
SCHEMBL7296406 0.80 MAPT (0.53) SMN1; SMN2MEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687220-B2 Oxime derivatives and use thereof as latent acids CIBA SPECIALTY CHEMICALS CORPORATION (US) 2010-03-30 US disclosed
US-20080085458-A1 Oxime Derivatives And Use Thereof As Latent Acids CIBA SPECIALTY CHEMICALS CORPORATION 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085458-A1 Oxime Derivatives And Use Thereof As Latent Acids ARSA, CYP2S1, QSOX1 SMN1; SMN2 3989/4885CASP3 2417/4885SENP8 4339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.